Panome Bio


Panome Bio is a leading biotechnology company dedicated to unlocking the full potential of multi-omics approaches, including metabolomics, proteomics, and transcriptomics. The company focuses on providing advanced, untargeted, and integrated multi-omics solutions to accelerate scientific discovery, biomarker identification, and mechanistic insights. With a mission to make next-generation functional phenotyping possible, Panome Bio offers comprehensive workflows, proprietary computational pipelines, and high-quality data reports to support groundbreaking research in health, disease, and biotechnology.

Industries

bioinformatics
biotechnology
data-integration-0c4a
life-science

Nr. of Employees

small (1-50)

Panome Bio

St Louis, Missouri, United States, North America


Products

Next-Generation Metabolomics

Panome Bio offers global, untargeted metabolomics assays to analyze small molecules and metabolites, providing a comprehensive view of metabolism.

Discovery Proteomics

Panome Bio provides mass spectrometry-based proteomic analysis to identify and quantify proteins, enabling insights into cellular processes and disease mechanisms.

Multi-Omic Integration

Panome Bio integrates metabolomics, proteomics, and transcriptomics data to understand molecular mechanisms and pathways.

Targeted Proteomics

Panome Bio uses multiplexed panels to quantify specific proteins, aiding in biomarker validation and disease monitoring.

Data Analysis Reports

Panome Bio delivers personalized data analysis reports with rigorous interpretation and tools for deep-dive analysis.

Metabolic Flux Analysis

Panome Bio tracks metabolic pathways using stable isotope labeling to provide insights into pathway regulation and disease states.


Services

Untargeted metabolomics and lipidomics services

Laboratory workflows for global metabolite and lipid profiling using untargeted mass spectrometry, with options for targeted follow-up panels and specialized analyses.

Metabolic flux analysis (stable isotope tracing)

Design and analysis of stable isotope tracer experiments and metabolic flux workflows to quantify pathway fluxes and metabolic fates.

Discovery and targeted proteomics

Mass spectrometry-based discovery proteomics for broad proteome coverage across sample types and targeted proteomics for precise quantitative validation, including global phosphoproteomics workflows.

Transcriptomics (mRNA sequencing)

mRNA sequencing services to profile gene expression and support integration with metabolomics and proteomics datasets.

Integrated multi-omics analysis and bioinformatics

Computational integration of metabolomics, proteomics, transcriptomics, and customer-provided datasets using a curated database and proprietary pipelines to produce unified, interpretable reports.

Sample logistics, preparation, and data delivery

End-to-end project handling including sample collection instructions, shipping guidance, standardized preparation, statistical analysis, and delivery of raw data and curated reports (typical report timelines stated).

Expertise Areas

  • Untargeted metabolomics
  • Lipidomics
  • Discovery proteomics
  • Targeted quantitative metabolomics and proteomics
  • Show More (10)

Key Technologies

  • Liquid chromatography–mass spectrometry (LC-MS)
  • Mass spectrometry-based proteomics
  • Nuclear magnetic resonance (NMR) metabolomics
  • Stable isotope tracer workflows (metabolic flux)
  • Show More (5)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.